| Subject: | FDA Advises of Serious Health Risk Associated with Compounded Topical Anesthetic Creams |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Mon, 11 Dec 2006 - 12:00 am |
| The FDA has notified healthcare professionals and consumers about the serious public health risks related to compounded topical anesthetic creams. The FDA has issued warning letters to five firms to stop compounding and distributing standardized versions of topical anesthetic creams, marketed for general distribution. The five firms are:
Triangle Compounding Pharmacy (Cary, NC)
University Pharmacy (Salt Lake City,... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
REFERENCE:
External Links:
|
|
StayAlert! notifies healthcare customers of all federal and regulatory body legislation changes impacting the healthcare industry, including TJC (JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG and many others. StayAlert! complements this with regulatory implementation action plans. StayAlert! serves as a virtual healthcare department, augmenting traditional employee staffed departments and freeing employees to perform other vital functions. The strength of StayAlert! rests in its ability to allow healthcare organizations to streamline their businesses using the Internet as a foundation architecture. StayAlert! provides cost containment and reduction through elimination of unnecessary overhead, and work caused by errors or poor access to information. |
|